APT Medical Inc. (SHA:688617)

Market Cap	32.08B -10.8%
Revenue (ttm)	2.58B +25.1%
Net Income	820.64M +21.9%
EPS	5.82 +22.0%
Shares Out	141.03M
PE Ratio	39.09
Forward PE	29.28
Dividend	1.21 (0.53%)
Ex-Dividend Date	Jun 19, 2025

Volume	2,599,367
Average Volume	1,086,816
Open	230.99
Previous Close	227.50
Day's Range	230.10 - 252.89
52-Week Range	223.48 - 337.20
Beta	-0.30
RSI	40.40
Earnings Date	Mar 25, 2026

About APT Medical

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. The company offers electrophysiology products, such as mapping, ablation, and navigated catheter, as well as steerable, and transseptal needle and sheet; and interventional cardiology and peripheral products, including access, diagnostic, therapeutic, and accessories. It also provides OEM/ODM service comprising project design and development, customization, and volume OEM for use in catheters, guidewires, del...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 2,915
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688617

Financial Performance

In 2025, APT Medical's revenue was 2.58 billion, an increase of 25.08% compared to the previous year's 2.07 billion. Earnings were 820.64 million, an increase of 21.91%.